129 related articles for article (PubMed ID: 9624233)
1. Should-alpha-interferon be included as standard treatment in multiple myeloma?
Ludwig H; Fritz E; Zulian GB; Browman GP
Eur J Cancer; 1998 Jan; 34(1):12-24. PubMed ID: 9624233
[No Abstract] [Full Text] [Related]
2. Interferon and multiple myeloma.
Lauta VM
Med Oncol; 1995 Mar; 12(1):63-9. PubMed ID: 8542250
[TBL] [Abstract][Full Text] [Related]
3. [Alpha-interferon in present-day treatment of myeloma].
Demina EA; Votiakova OM
Gematol Transfuziol; 1996; 41(2):32-6. PubMed ID: 8754159
[No Abstract] [Full Text] [Related]
4. [Use of interferon alpha in multiple myeloma].
Harousseau JL; Klein B
Rev Med Interne; 1996; 17(6):488-95. PubMed ID: 8758538
[TBL] [Abstract][Full Text] [Related]
5. [Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma].
García Laraña J; Díaz Mediavilla J; Martínez R; Lahuerta JJ; Alegre A; Odriozola J; Sureda A; San Miguel J; De la Rubia J; Escudero A; Conde E; Bladé J; Cabrera R; Gastearena J; Besalduch J; Vidal MJ; Hernández F; Rifon J; Leon A; Mataix R; Parody R; Moraleda JM; Solano C; de Pablos JM; Sánchez JJ
Sangre (Barc); 1997 Apr; 42 Suppl 1():38-41. PubMed ID: 9381300
[No Abstract] [Full Text] [Related]
6. A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results.
Cunningham D; Powles R; Malpas J; Raje N; Milan S; Viner C; Montes A; Hickish T; Nicolson M; Johnson P; Treleaven J; Raymond J; Gore M
Br J Haematol; 1998 Jul; 102(2):495-502. PubMed ID: 9695964
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy of MCNU and interferon alfa-2a (genetical recombination) for advanced multiple myeloma].
Hino N; Matsuura W; Kawakami K; Ono T; Matsumoto T; Tominaga T
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):693-6. PubMed ID: 2321988
[No Abstract] [Full Text] [Related]
8. Maintenance therapy and supportive care for patients with multiple myeloma.
Kyle RA
Semin Oncol; 1999 Oct; 26(5 Suppl 13):35-42. PubMed ID: 10528893
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha as maintenance therapy in patients with multiple myeloma.
Yalcin B; Dogan M; Buyukcelik A; Doruk H; Tek I; Demirkazik A
Ann Oncol; 2005 Dec; 16(12):1981. PubMed ID: 16081472
[No Abstract] [Full Text] [Related]
10. Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience.
Cohen AM; Meytes D; Many A; Brenner B; Aghai E; Shaklai M; Kaufman S; Shtalrid M; Attias D; Manor Y
Isr J Med Sci; 1995 Oct; 31(10):604-10. PubMed ID: 7591683
[TBL] [Abstract][Full Text] [Related]
11. Modulation of chemosensitivity by alpha interferon in multiple myeloma and non-Hodgkin's lymphoma.
Iaffaioli RV; Facchini G; Tortoriello A; Scala S; Pacelli R; La Mura G; Pagliarulo C; Palmieri G; Caponigro F
J Exp Ther Oncol; 1996 Jul; 1(4):226-30. PubMed ID: 9414408
[TBL] [Abstract][Full Text] [Related]
12. MRC trial of alpha2b-interferon maintenance therapy in first plateau phase of multiple myeloma. MRC Working Party on Leukaemia in Adults.
Drayson MT; Chapman CE; Dunn JA; Olujohungbe AB; Maclennan IC
Br J Haematol; 1998 Apr; 101(1):195-202. PubMed ID: 9576201
[TBL] [Abstract][Full Text] [Related]
13. Interferon alfa-2a.
Williams CD; Linch DC
Br J Hosp Med; 1997 May 7-20; 57(9):436-9. PubMed ID: 9274677
[TBL] [Abstract][Full Text] [Related]
14. A review of the clinical studies of alpha-interferon in the management of multiple myeloma.
Cooper MR
Semin Oncol; 1991 Oct; 18(5 Suppl 7):18-29. PubMed ID: 1948125
[TBL] [Abstract][Full Text] [Related]
15. Interferon in the treatment of multiple myeloma and non Hodgkins lymphoma.
Smruti BK; Nair R; Gopal R
J Assoc Physicians India; 1995; Suppl 3():33-7. PubMed ID: 8773120
[No Abstract] [Full Text] [Related]
16. Innovative treatment strategies for non-Hodgkin's lymphoma and multiple myeloma.
Borden EC
Semin Oncol; 1994 Dec; 21(6 Suppl 14):14-22. PubMed ID: 7992095
[TBL] [Abstract][Full Text] [Related]
17. Interferon does not prevent leukemic evolution in patients with multiple myeloma.
Remes K; Paul R; Pelliniemi TT
Leukemia; 1993 Jul; 7(7):1072-3. PubMed ID: 8321024
[No Abstract] [Full Text] [Related]
18. Long-term survival in a case of high-risk type IgD myeloma; a possibility of effectiveness of interferon-alpha and erythropoietin.
Hiyoshi M; Hashimoto S; Ota T; Nakao T; Takubo T; Tagawa S; Tatsumi N
Haematologia (Budap); 1997; 28(3):177-80. PubMed ID: 9283919
[TBL] [Abstract][Full Text] [Related]
19. Serum beta-2-microglobulin in patients with multiple myeloma treated with alpha interferon.
Murakami H; Ogawara H; Morita K; Saitoh T; Matsushima T; Tamura J; Sawamura M; Karasawa M; Miyawaki S; Schimano S; Satoh S; Tsuchiya J
J Med; 1997; 28(5-6):311-8. PubMed ID: 9604789
[TBL] [Abstract][Full Text] [Related]
20. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.
Mandelli F; Avvisati G; Amadori S; Boccadoro M; Gernone A; Lauta VM; Marmont F; Petrucci MT; Tribalto M; Vegna ML
N Engl J Med; 1990 May; 322(20):1430-4. PubMed ID: 2184356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
